GI-MAP (Gastrointestinal Microbial Assay Plus)
Comprehensive panel for intestinal microorganism analysis, immune and digestive markers
Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample, using modern qPCR (quantitative polymerase chain reaction) technology.
The GI-MAP test was designed to detect microorganisms that can disrupt the balance of the intestinal microbiota or contribute to the onset of conditions, as well as to evaluate indicators of:
- digestion
- nutrient absorption
- inflammation
- immune system function
In the case of culture-based microbiological tests, strict anaerobes, viruses, or virulence factors cannot be measured. GI-MAP overcomes these limitations.
The accuracy and reliability of the GI-MAP test allow for the development of personalized treatment protocols for intestinal dysfunctions, depending on:
- infections requiring urgent intervention
- areas of the intestinal tract that are already functioning optimally
- aspects to be addressed after an infection has been resolved
Also, quantification of identified microorganisms allows for monitoring treatment effectiveness. Repeating the test after therapy can show, for example, whether:
- a parasite has been eliminated
- intestinal dysbiosis has improved
- microbiota balance has improved
Indications
The test may be useful in the following situations:
- autoimmune molecular mimicry (if caused by pathogens)
- diarrhea
- digestive problems
- foodborne illnesses
- gastritis
- gastroenteritis (especially of viral origin)
- intestinal dysbiosis
- immune system evaluation
- intestinal inflammation
- suspected bacterial, parasitic, or viral infections (including detection of antibiotic-resistant bacteria)
*Images are for informational purposes only and may differ from the actual product.
